PATENT CLAIM ANALYSIS

Application Number: 15754806
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "175000"]

Abstract:
Disclosed herein are novel sialyltransferase inhibitors, and compositions and methods for treating diseases and/or conditions associated with the activation of sialyltransferase, such as a cancer, an immune disease or an inflammatory disease.

Claim (Index 24):
The method of  claim 18 , wherein the inflammatory disease is any of diabetic retinopathy, proliferative retinopathy, dermatitis, eczema, atopic dermatitis, allergic contact dermatitis, urticaria, necrotizing vasculitis, cutaneous vasculitis, hypersensitivity vasculitis, eosinophilic myositis, polymyositis, dermatomyositis, eosinophilic fasciitis, Crohn's disease, ulcerative colitis, hypersensitivity pneumonitis, eosinophilic pneumonia, delayed-type hypersensitivity, interstitial lung disease (ILD), idiopathic pulmonary fibrosis, and ILD associated with rheumatoid arthritis, macular edema, asthma, or allergic rhinitis.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 88.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13540940', '12595357', '11480174', '14094027', '15222734']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7659186265354931
- 35 USC 102 Novelty (BERT): 0.5352997147689675
- Combined Prediction Score: 0.7428567353588406
- Mean Citation Score: 302.165564
- Max Citation Score: 319.4755600000001
- Similarity Product: 174.20713064311985

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test